Driving fibroblast-immune conversations in cancer and inflammatory diseases
Promoting disease resolution
Activated fibroblasts play an important and often overlooked role in driving the immune system’s response in cancer and inflammatory diseases. At Mestag, we are developing urgently needed new therapies that harness fibroblast-immune conversations to re-establish the immune system’s proper function for patients who do not benefit from current treatments.
Our vision is significantly improved lives for people affected by inflammatory disease and cancer.